HCPCS J1595: Injection, Glatiramer Acetate, 20 mg
HCPCS Level II code J1595 represents a billed injectable medication product: injection, glatiramer acetate, 20 mg, typically administered as a subcutaneous injection for disease-modifying therapy; service type is medication administration and the typical site of service is outpatient clinic or physician office infusion/injection suite.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J1595 policy alerts
Get alerted when payer policies referencing J1595 are released or updated.
Monitor payer policy activity